• +1-646-491-9876
    • +91-20-67278686

    Search

    Pontine Glioma-Pipeline Review H1 2017

    Pontine Glioma-Pipeline Review H1 2017

    • Report Code ID: RW0001834406
    • Category Pharmaceuticals
    • No. of Pages 148
    • Publication Month Jun-17
    • Publisher Name Global Markets Direct
    Pontine Glioma - Pipeline Review, H1 2017

    Summary

    Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Pontine Glioma - Pipeline Review, H1 2017, provides an overview of the Pontine Glioma (Oncology) pipeline landscape.

    Pontine gliomas are highly aggressive and difficult to treat brain tumors found at the base of the brain. One of the most common types is diffuse intrinsic pontine glioma (DIPG) . DIPG affects the pons portion of the brainstem, rendering nervous system function impossible. Symptoms include double vision, inability to close the eyelids completely, dropping one side of the face, and difficulty chewing and swallowing.

    Report Highlights

    Publisher's Pharmaceutical and Healthcare latest pipeline guide Pontine Glioma - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Pontine Glioma (Oncology) , complete with analysis by stage of development, drug target, mechanism of action (MoA) , route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

    The Pontine Glioma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Pontine Glioma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical and Discovery stages are 6, 5, 7 and 2 respectively. Similarly, the Universities portfolio in Phase I stages comprises 2 molecules, respectively.

    Pontine Glioma (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

    Scope

    - The pipeline guide provides a snapshot of the global therapeutic landscape of Pontine Glioma (Oncology) .
    - The pipeline guide reviews pipeline therapeutics for Pontine Glioma (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in Pontine Glioma (Oncology) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates Pontine Glioma (Oncology) therapeutics based on mechanism of action (MoA) , drug target, route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for Pontine Glioma (Oncology)

    Reasons to buy

    - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for Pontine Glioma (Oncology) .
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding Pontine Glioma (Oncology) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
    Table of Contents
    List of Tables
    List of Figures
    Introduction
    Publisher Report Coverage
    Pontine Glioma - Overview
    Pontine Glioma - Therapeutics Development
    Pipeline Overview
    Pipeline by Companies
    Pipeline by Universities/Institutes
    Products under Development by Companies
    Products under Development by Universities/Institutes
    Pontine Glioma - Therapeutics Assessment
    Assessment by Target
    Assessment by Mechanism of Action
    Assessment by Route of Administration
    Assessment by Molecule Type
    Pontine Glioma - Companies Involved in Therapeutics Development
    AbbVie Inc
    Arog Pharmaceuticals Inc
    AstraZeneca Plc
    Boehringer Ingelheim GmbH
    Bristol-Myers Squibb Company
    Burzynski Research Institute Inc
    Insys Therapeutics Inc
    Loxo Oncology Inc
    Medicenna Therapeutics Corp
    Midatech Pharma Plc
    Novogen Ltd
    Ono Pharmaceutical Co Ltd
    Pfizer Inc
    Sanofi
    ZIOPHARM Oncology Inc
    Pontine Glioma - Drug Profiles
    (A-10 + AS-21) - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    AdRTSIL-12 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    afatinib dimaleate - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    AZD-1775 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    cabazitaxel - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    cannabidiol - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Cellular Immunotherapy for Pediatric Diffuse Intrinsic Pontine Glioma - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    crenolanib besylate - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    depatuxizumab mafodotin - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    ipilimumab + nivolumab - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    larotrectinib - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    MDNA-55 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Monoclonal Antibody Conjugate to Target B7H3 for Pediatric Diffuse Intrinsic Pontine Glioma - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    MTX-110 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    MTX-111 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    nivolumab - Drug Profile
    R&D Progress
    ORX-101 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    p28 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    pidilizumab - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Trilexium - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Vaccine for Pontine Glioma - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    VIMO-001 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Pontine Glioma - Dormant Projects
    Pontine Glioma - Product Development Milestones
    Featured News & Press Releases
    Jul 11, 2016: AbbVie Receives U.S. FDA Rare Pediatric Disease Designation for Investigational ABT-414 for the Treatment of a Type of Pediatric Brain Tumor known as Diffuse Intrinsic Pontine Glioma (DIPG)
    Feb 19, 2016: Novogen Patent Covering Trilexium Has Been Proceeded To Grant
    Jun 04, 2015: Studies Confirm TRXE-009 Crosses the Blood-brain Barrier
    May 08, 2015: Australian Studies Confirm TRXE-009 Kills Resistant Paediatric Brain Cancer Cells
    Appendix
    Methodology
    Coverage
    Secondary Research
    Primary Research
    Expert Panel Validation
    Contact Us
    Disclaimer

    List of Tables

    Number of Products under Development for Pontine Glioma, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017
    Products under Development by Companies, H1 2017
    Products under Development by Companies, H1 2017 (Contd..1) , H1 2017
    Products under Development by Universities/Institutes, H1 2017
    Number of Products by Stage and Target, H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017
    Number of Products by Stage and Route of Administration, H1 2017
    Number of Products by Stage and Molecule Type, H1 2017
    Pontine Glioma - Pipeline by AbbVie Inc, H1 2017
    Pontine Glioma - Pipeline by Arog Pharmaceuticals Inc, H1 2017
    Pontine Glioma - Pipeline by AstraZeneca Plc, H1 2017
    Pontine Glioma - Pipeline by Boehringer Ingelheim GmbH, H1 2017
    Pontine Glioma - Pipeline by Bristol-Myers Squibb Company, H1 2017
    Pontine Glioma - Pipeline by Burzynski Research Institute Inc, H1 2017
    Pontine Glioma - Pipeline by Insys Therapeutics Inc, H1 2017
    Pontine Glioma - Pipeline by Loxo Oncology Inc, H1 2017
    Pontine Glioma - Pipeline by Medicenna Therapeutics Corp, H1 2017
    Pontine Glioma - Pipeline by Midatech Pharma Plc, H1 2017
    Pontine Glioma - Pipeline by Novogen Ltd, H1 2017
    Pontine Glioma - Pipeline by Ono Pharmaceutical Co Ltd, H1 2017
    Pontine Glioma - Pipeline by Pfizer Inc, H1 2017
    Pontine Glioma - Pipeline by Sanofi, H1 2017
    Pontine Glioma - Pipeline by ZIOPHARM Oncology Inc, H1 2017
    Pontine Glioma - Dormant Projects, H1 2017

    List of Figures

    Number of Products under Development for Pontine Glioma, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products by Top 10 Targets, H1 2017
    Number of Products by Stage and Top 10 Targets, H1 2017
    Number of Products by Top 10 Mechanism of Actions, H1 2017
    Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
    Number of Products by Routes of Administration, H1 2017
    Number of Products by Stage and Routes of Administration, H1 2017
    Number of Products by Molecule Types, H1 2017
    Number of Products by Stage and Molecule Types, H1 2017
    AbbVie Inc
    Arog Pharmaceuticals Inc
    AstraZeneca Plc
    Boehringer Ingelheim GmbH
    Bristol-Myers Squibb Company
    Burzynski Research Institute Inc
    Insys Therapeutics Inc
    Loxo Oncology Inc
    Medicenna Therapeutics Corp
    Midatech Pharma Plc
    Novogen Ltd
    Ono Pharmaceutical Co Ltd
    Pfizer Inc
    Sanofi
    ZIOPHARM Oncology Inc

    Request for Sample

    Report Url https://www.reportsweb.com//pontine-glioma-pipeline-review-h1-2017&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url https://www.reportsweb.com//pontine-glioma-pipeline-review-h1-2017&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url https://www.reportsweb.com//pontine-glioma-pipeline-review-h1-2017&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments